484 related articles for article (PubMed ID: 31312198)
1. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.
Hübner F; Langan EA; Recke A
Front Immunol; 2019; 10():1389. PubMed ID: 31312198
[TBL] [Abstract][Full Text] [Related]
2. Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus.
Papara C; Danescu S; Sitaru C; Baican A
Australas J Dermatol; 2022 May; 63(2):165-171. PubMed ID: 35196400
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
4. Lichen Planus Pemphigoides Mimicking Toxic Epidermal Necrolysis.
Ondhia C; Kaur C; Mee J; Natkunarajah J; Singh M
Am J Dermatopathol; 2019 Nov; 41(11):e144-e147. PubMed ID: 31145106
[TBL] [Abstract][Full Text] [Related]
5. Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.
Combemale L; Bohelay G; Sitbon IY; Ahouach B; Alexandre M; Martin A; Pascal F; Soued I; Doan S; Morin F; Grootenboer-Mignot S; Caux F; Prost-Squarcioni C; Le Roux-Villet C
Front Immunol; 2024; 15():1243566. PubMed ID: 38686381
[TBL] [Abstract][Full Text] [Related]
6. A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1.
Sekiya A; Kodera M; Yamaoka T; Iwata Y; Usuda T; Ohzono A; Yasukochi A; Koga H; Ishii N; Hashimoto T
Br J Dermatol; 2014 Nov; 171(5):1230-5. PubMed ID: 24813536
[TBL] [Abstract][Full Text] [Related]
7. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
8. Bullous lichen planus accompanied by elevation of serum anti-BP180 autoantibody: A possible transitional mechanism to lichen planus pemphigoides.
Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
J Dermatol; 2017 Jun; 44(6):e124-e125. PubMed ID: 28105695
[No Abstract] [Full Text] [Related]
9. Lichen planus pemphigoides induced by a weight reduction drug.
Rosmaninho A; Sanches M; Oliveira A; Alves R; Selores M
Cutan Ocul Toxicol; 2011 Dec; 30(4):306-8. PubMed ID: 21428725
[TBL] [Abstract][Full Text] [Related]
10. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
[TBL] [Abstract][Full Text] [Related]
11. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer.
Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S
J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550
[No Abstract] [Full Text] [Related]
12. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
Hsu S; Ghohestani RF; Uitto J
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
[TBL] [Abstract][Full Text] [Related]
13. Childhood lichen planus pemphigoides: a case report and review of the literature.
Cohen DM; Ben-Amitai D; Feinmesser M; Zvulunov A
Pediatr Dermatol; 2009; 26(5):569-74. PubMed ID: 19840313
[TBL] [Abstract][Full Text] [Related]
14. Atypical subacute cutaneous lupus erythematosus presenting as lichen planus pemphigoides with autoantibodies to C-terminus of BP180, desmoglein 1 and SS-A/Ro antigen.
Inoue Y; Adachi A; Ueno M; Fukumoto T; Nishitani N; Fujiwara N; Yamada Y; Ohyama B; Tsuruta D; Hashimoto T
J Dermatol; 2012 Nov; 39(11):960-2. PubMed ID: 22413755
[No Abstract] [Full Text] [Related]
15. Lichen planus pemphigoides evolving into pemphigoid nodularis.
Sakuma-Oyama Y; Powell AM; Albert S; Oyama N; Bhogal BS; Black MM
Clin Exp Dermatol; 2003 Nov; 28(6):613-6. PubMed ID: 14616828
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
Olasz EB; Yancey KB
Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
[TBL] [Abstract][Full Text] [Related]
17. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
[TBL] [Abstract][Full Text] [Related]
18. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
Shipman AR; Cooper S; Wojnarowska F
Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
[TBL] [Abstract][Full Text] [Related]
19. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
Sato Y; Fujimura T; Mizuashi M; Aiba S
J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
[No Abstract] [Full Text] [Related]
20. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]